Effect of isatuximab plus pomalidomide/dexamethasone on renal impairment in relapsed/refractory multiple myeloma: ICARIA-MM study subgroup analysis — Meletios A Dimopoulos (2019) | RDL Network
Meletios A Dimopoulos, Xavier Leleu, Philippe Moreau, Paul G. Richardson, Anna Marina Liberati, Simon J. Harrison, H. Miles Prince, Enrique M. Ocio, Sylvie Assadourian, Frank Campana, Laure Malinge, Dorothée Sémiond, Helgi van de Velde, Kwee Yong
Fredrik Schjesvold, Sara Bringhen, Paul G. Richardson, Aurore Perrot, Xavier Leleu, Philippe Moreau, Meletios A Dimopoulos, Cyrille Hulin, Christina Tekle, Meredith C. Foster, Elizabeth M. Poole, Helgi van de Velde, Thierry Façon
Marcelo Capra, Thomas G. Martin, Philippe Moreau, Ross Baker, Luděk Pour, Chang‐Ki Min, Xavier Leleu, Mohamad Mohty, Marta Reinoso Segura, Mehmet Turgut, Richard LeBlanc, Marie‐Laure Risse, Laure Malinge, Sandrine Schwab, Meletios A Dimopoulos
Marcelo Capra, Thomas G. Martin, Philippe Moreau, Ross Baker, Luděk Pour, Chang‐Ki Min, Xavier Leleu, Mohamad Mohty, Marta Reinoso Segura, Mehmet Turgut, Richard LeBlanc, Marie‐Laure Risse, Laure Malinge, Sandrine Schwab, Meletios A Dimopoulos
Discussion(0)
No comments yet. Be the first to comment.